Data as of Mar 07
| +0.01 / +0.58%|
The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +15.61% increase from the last price of 1.73.
The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.